Principal Investigator
Principal Investigator
Dr. Arshad Ayyaz
Assistant Professor,
Department of Biological Sciences, Faculty of Science, University of Calgary, 2500 University Dr NW, Calgary, AB T2N 1N4, Canada
arshad.ayyaz[at]ucalgary.ca
Dr. Ayyaz is a geneticist and stem-cell biologist whose research investigates how somatic stem cells sustain tissue homeostasis, regenerate injured organs, and become dysregulated in chronic inflammation and cancer. By integrating genetic models, organoids, lineage tracing, and single-cell and multi-omic technologies, his work connects fundamental mechanisms of stem-cell biology with tissue repair, disease progression, and therapeutic resistance.
A defining contribution of Dr. Ayyaz’s research was the discovery of the revival stem cell (revSC), a rare, damage-induced cell state identified through single-cell transcriptomic analysis of the regenerating intestine. Although scarcely detectable during homeostasis, revSCs emerge following severe injury and regenerate the intestinal epithelium by reconstituting the Lgr5⁺ stem-cell compartment and producing the major epithelial lineages (Ayyaz et al., 2019, Nature). He subsequently helped establish p53 as a critical regulator of this response. Transient p53 activation is required to induce fetal-like revSCs after severe radiation injury, whereas sustained activation impairs regeneration, demonstrating how the p53–MDM2 feedback loop precisely controls epithelial repair (Morral, Ayyaz, Kuo et al., 2024, Nature Communications). Complementary multi-omic work further demonstrated that damage-induced chromatin remodelling converges on transient TGFβ and Hippo signalling to generate functional revSCs (Fink et al., 2024, Nature Cell Biology).
Building on these discoveries, Dr. Ayyaz’s laboratory addressed a prevailing controversy concerning the organization of the intestinal epithelial hierarchy. Recent models had challenged the central role of Lgr5⁺ crypt-base-columnar cells by proposing that Fgfbp1⁺ isthmus progenitors or other Lgr5-negative populations occupy a hierarchically upstream position. By integrating quantitative lineage tracing with single-cell transcriptomic, chromatin-accessibility, spatial, and functional analyses, his team provided comprehensive evidence that Lgr5⁺ cells occupy the apex of the small-intestinal epithelial hierarchy and sustain epithelial turnover along the entire intestine. The study further showed that Fgfbp1⁺ cells are downstream progenitors rather than an upstream stem-cell population. Following severe injury, transient fetal-like states—including revSCs—restore the Lgr5⁺ compartment through an essential R-spondin–WNT/β-catenin-dependent program. These findings reconcile cellular plasticity with the classical stem-cell hierarchy by demonstrating that regenerative reprogramming ultimately reinstates, rather than replaces, Lgr5⁺ stem-cell identity (Chua et al., 2026, Nature Communications).
Dr. Ayyaz has also defined how inflammatory signals regulate stem-cell behaviour. His earlier work demonstrated that macrophage-like innate immune cells coordinate intestinal regeneration through temporally regulated BMP/DPP signalling. Following tissue damage, these cells stimulate stem-cell proliferation through SAX–SMOX signalling; subsequent receptor switching to TKV–MAD restores stem-cell quiescence. This work connected immune–stem-cell communication with epithelial regeneration and resistance to enteric infection while demonstrating how persistent activation of the same pathways can promote age-associated intestinal dysplasia (Ayyaz et al., 2015, Nature Cell Biology).
As senior author, Dr. Ayyaz recently identified WNT/β-catenin-inhibitory cancer cells (WICCs), a stem-like tumour population enriched in advanced microsatellite-stable colorectal cancer. WICCs express extracellular WNT antagonists, including NOTUM, and are associated with immune-excluded tumours and reduced CD8⁺ T-cell infiltration. Selective WICC ablation or NOTUM deletion enhances CD8⁺ T-cell-mediated cytotoxicity, revealing a tumour-intrinsic mechanism of immune resistance and a potentially tractable therapeutic vulnerability for improving immunotherapy responses (Chua et al., 2026, Cell Reports Medicine).
Dr. Ayyaz’s research further examines how biochemical, cellular, microbial, and mechanical features of the tissue microenvironment regulate stem-cell identity. Collaborative work established PIEZO-dependent mechanosensing as an essential regulator of intestinal stem-cell fate and maintenance (Baghdadi et al., 2024, Science). Other studies have revealed how enteric glial heterogeneity shapes intestinal stem-cell niches, microbiome-induced AKT signalling supports epithelial homeostasis and regeneration, and PIWI-dependent genome maintenance protects somatic stem cells from age-associated exhaustion (Baghdadi et al., 2021, Cell Stem Cell; Goldsmith et al., 2020, Nature Communications; Sousa-Victor et al., 2017, Cell Reports). His collaborative research has also used in vivo CRISPR screening to identify regulators of immunotherapy response in cancer (Dervovic et al., 2023, Nature Communications). Collectively, these studies position his research at the intersection of stem-cell biology, regeneration, inflammation, cancer, and therapeutic resistance.
Affiliations
Assistant Professor (2022-present) | Department of Biological Sciences, Faculty of Science, University of Calgary, Canada
The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Canada
The Riddell Centre for Cancer Immunotherapy, Cumming School of Medicine, University of Calgary, Canada
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Canada
Education
Scientist (2016-2021): Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, Canada
Postdoctoral Fellow (2015-2016): The Institute for Research in Immunology and Cancer, Montreal, Canada
Postdoctoral Fellow (2012-2015): Buck Institute for Research on Aging, California, USA
Ph.D. (2008-2012): University of Strasbourg, Strasbourg, France
Master (2007-2008): Louis Pasteur University, Strasbourg, France